| | Public offering price(1) | | | Underwriting discount | | | Proceeds, before expenses, to us | ||||||||||
| | $ | | | % | | | $ | | | % | | | $ | | | % | |
Per 2024 Note | | | $449,469,000 | | | 99.882% | | | $1,575,000 | | | 0.350% | | | $447,894,000 | | | 99.532% |
Per 2031 Note | | | $548,592,000 | | | 99.744% | | | $3,575,000 | | | 0.650% | | | $545,017,000 | | | 99.094% |
Total | | | $998,061,000 | | | | | $5,150,000 | | | | | $992,911,000 | | |
(1) | Plus accrued interest from August 18, 2021, if settlement occurs after that date. See “Alternative Settlement Cycle”. |
J.P. Morgan | | | BofA Securities | | | Wells Fargo Securities |
US Bancorp | | | Citizens Capital Markets | | | Truist Securities |
BMO Capital Markets | | | Citigroup | | | KBC Securities USA |